Company · Mississauga, Ontario, Canada
Ascend Laboratories Ltd
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 9
- 9 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ASN-CEPHALEXIN | 02496445 | Approved | |
| ASN-CEPHALEXIN | 02496453 | Approved | |
| ASN-DRONEDARONE | 02514397 | Approved | |
| ASN-FINGOLIMOD | 02500914 | Approved | |
| ASN-HYDRALAZINE | 02493640 | Approved | |
| ASN-HYDRALAZINE | 02493659 | Approved | |
| ASN-HYDRALAZINE | 02493667 | Approved | |
| ASN-RASAGILINE | 02489120 | Approved | |
| ASN-RASAGILINE | 02489139 | Approved |
Notices of Compliance
Newest first.
- ASN-CEPHALEXINJune 30, 2026 · NOC 37816 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ASN-DRONEDARONEMarch 29, 2021 · NOC 25532 · Abbreviated New Drug Submission (ANDS)
- ASN-CEPHALEXINMarch 4, 2021 · NOC 25363 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ASN-FINGOLIMODJune 23, 2020 · NOC 23825 · Abbreviated New Drug Submission (ANDS)
- ASN-CEPHALEXINFebruary 21, 2020 · NOC 23236 · Abbreviated New Drug Submission (ANDS)
- ASN-HYDRALAZINENovember 5, 2019 · NOC 22876 · Abbreviated New Drug Submission (ANDS)
- ASN-RASAGILINEJune 4, 2019 · NOC 22235 · Abbreviated New Drug Submission (ANDS)